Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218504 · ClinicalTrials.gov registry record
Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00218504: Completed study, sponsored by Wayne State University.
NCT00218504 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218504 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana responsible for its reinforcing effects, may decrease marijuana cravings. The purpose of this study is to evaluate the effect of THC pre-treatment on responses to marijuana-related cues versus non marijuana-related cues in individuals addicted to marijuana.
Interventions
- DRUG Tetrahydrocannabinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-10 |
What the finished NCT00218504 record still lists
NCT00218504 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tetrahydrocannabinol is the first listed.
NCT00218504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218504 about?
NCT00218504 is a clinical study titled "Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2". The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana respons...
What is the current status of trial NCT00218504?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00218504?
The interventions under investigation include: Tetrahydrocannabinol (DRUG).
Who is sponsoring clinical trial NCT00218504?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia